Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine and Small Molecule Treatment of Tumors


Publishing date
01 Sep 2022
Status
Published
Submission deadline
13 May 2022

Lead Editor

1Daping Hospital, Army Medical University, Chongqing, China

2Chongqing University, Chongqing, China

3Sichuan Cancer Hospital, Chengdu, China

4Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

5UT Southwestern Medical Center, Dallas, USA


Traditional Chinese Medicine and Small Molecule Treatment of Tumors

Description

The effective ingredients of Chinese herbal medicine (CHM) compounds can affect the progress of tumors at the epigenetic level and can have an effect in different pathological stages of tumors. Active ingredients and mechanisms have multiple pathways and multiple targets.

At present, there is insufficient basic research, unclear intervention effects and mechanisms on the dynamic process of disease, and relatively isolated research on various factors of epigenetic modification. In-depth research is still needed, and the results will be transformed into clinical applications.

The purpose of this Special Issue is to gather original research and review articles on the activity and mechanism of traditional Chinese medicine molecules and to provide high-quality evidence on the mechanism of action of Chinese herbal medicines and monomer drugs in the treatment of tumors. Systematic reviews are particularly welcome.

Potential topics include but are not limited to the following:

  • The efficacy and mechanism of CHM in the treatment of tumors (such as tumors of the gastrointestinal system, nervous system, respiratory system, bone tumors, gynecological tumors, urinary system, etc.)
  • Studies of the mechanism of CHM in treating tumors in vivo and in vitro
  • Evaluation of toxicity of Traditional Chinese Medicine in treating tumors
  • Extraction and reconstruction of new types of Chinese Medicine in treating tumors
  • Pharmacokinetic analysis of new Chinese medicines and small molecule drugs in treating tumors
  • Safety and effectiveness of new Chinese medicine and small molecule drugs in the treatment of tumors

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9890723
  • - Retraction

Retracted: m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9893765
  • - Retraction

Retracted: Exploration of Potential Biomarkers and Immune Landscape for Hepatoblastoma: Evidence from Machine Learning Algorithm

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9863491
  • - Retraction

Retracted: Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9764530
  • - Retraction

Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9857062
  • - Retraction

Retracted: Statins on Spontaneous Intracerebral Hemorrhage: A Meta-Analysis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9873478
  • - Retraction

Retracted: Meta-Analysis of the Efficacy and Safety of Chlorhexidine for Ventilator-Associated Pneumonia Prevention in Mechanically Ventilated Patients

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9875085
  • - Retraction

Retracted: Efficacy of Duhuo Jisheng Decoction in Treating Ankylosing Spondylitis: Clinical Evidence and Potential Mechanisms

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9848230
  • - Retraction

Retracted: Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9841358
  • - Retraction

Retracted: Cisapride versus Maren Pill for Functional Constipation: A Meta-Analysis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9812091
  • - Retraction

Retracted: Efficacy of Dexamethasone versus Dexmedetomidine Combined with Local Anaesthetics in Brachial Plexus Block: A Meta-Analysis and Systematic Review

Evidence-Based Complementary and Alternative Medicine
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.